Mangalam Drugs And Organics Limited — Others, 19-05-2025: Copy of Newspaper Publication

Equirus Wealth Private Limited has surrendered its SEBI research analyst registration, with grievances directed to their compliance officer. Kay Kay Trading Co seeks to convert from a partnership to a company focusing on mineral trading, inviting objections. IndiaMART InterMESH Limited has announced a board meeting to consider the financial results for the quarter and half-year and proposed a dividend of Rs. 50 per equity share, subject to member approval; the AGM will be held via video conferencing with remote voting. NSDL updated its IPO prospectus with revised financials and risk factors; the IPO offers up to 50.15 million shares via selling shareholders, including major banks, with employee reservations. Mangalam Drugs & Organics reported annual income of Rs. 73.04 Cr and net profit of Rs. 6.92 Cr, with EPS at Rs. 4.37.